Vycor Medical Stock Probability of Future OTC Stock Price Finishing Over 36.68

VYCO Stock  USD 0.07  0.00  0.00%   
Vycor Medical's future price is the expected price of Vycor Medical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Vycor Medical performance during a given time horizon utilizing its historical volatility. Check out Vycor Medical Backtesting, Vycor Medical Valuation, Vycor Medical Correlation, Vycor Medical Hype Analysis, Vycor Medical Volatility, Vycor Medical History as well as Vycor Medical Performance.
  
Please specify Vycor Medical's target price for which you would like Vycor Medical odds to be computed.

Vycor Medical Target Price Odds to finish over 36.68

The tendency of Vycor OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 36.68  or more in 90 days
 0.07 90 days 36.68 
close to zero percent
Based on a normal probability distribution, the odds of Vycor Medical to move over $ 36.68  or more in 90 days from now is close to zero percent (This Vycor Medical probability density function shows the probability of Vycor OTC Stock to fall within a particular range of prices over 90 days) . Probability of Vycor Medical price to stay between its current price of $ 0.07  and $ 36.68  at the end of the 90-day period is about 84.03 .
Given the investment horizon of 90 days Vycor Medical has a beta of -1.56. This entails as returns on its benchmark rise, returns on holding Vycor Medical are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Vycor Medical is expected to outperform its benchmark. Additionally Vycor Medical has an alpha of 0.5681, implying that it can generate a 0.57 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Vycor Medical Price Density   
       Price  

Predictive Modules for Vycor Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vycor Medical. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vycor Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0711.58
Details
Intrinsic
Valuation
LowRealHigh
0.000.0611.57
Details

Vycor Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Vycor Medical is not an exception. The market had few large corrections towards the Vycor Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vycor Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vycor Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.57
β
Beta against Dow Jones-1.56
σ
Overall volatility
0.01
Ir
Information ratio 0.04

Vycor Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vycor Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vycor Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Vycor Medical is way too risky over 90 days horizon
Vycor Medical has some characteristics of a very speculative penny stock
Vycor Medical appears to be risky and price may revert if volatility continues
Vycor Medical has a very high chance of going through financial distress in the upcoming years
Vycor Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Vycor Medical currently holds 150 K in liabilities with Debt to Equity (D/E) ratio of 390.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vycor Medical has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vycor Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Vycor Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vycor Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vycor to invest in growth at high rates of return. When we think about Vycor Medical's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 1.39 M. Net Loss for the year was (435.66 K) with profit before overhead, payroll, taxes, and interest of 1.26 M.
About 65.0% of Vycor Medical outstanding shares are owned by insiders

Vycor Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vycor OTC Stock often depends not only on the future outlook of the current and potential Vycor Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vycor Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding30.8 M
Short Long Term Debt640.2 K
Shares Float12.1 M

Vycor Medical Technical Analysis

Vycor Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Vycor OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vycor Medical. In general, you should focus on analyzing Vycor OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Vycor Medical Predictive Forecast Models

Vycor Medical's time-series forecasting models is one of many Vycor Medical's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vycor Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Vycor Medical

Checking the ongoing alerts about Vycor Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vycor Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Vycor Medical is way too risky over 90 days horizon
Vycor Medical has some characteristics of a very speculative penny stock
Vycor Medical appears to be risky and price may revert if volatility continues
Vycor Medical has a very high chance of going through financial distress in the upcoming years
Vycor Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Vycor Medical currently holds 150 K in liabilities with Debt to Equity (D/E) ratio of 390.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vycor Medical has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vycor Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Vycor Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vycor Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vycor to invest in growth at high rates of return. When we think about Vycor Medical's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 1.39 M. Net Loss for the year was (435.66 K) with profit before overhead, payroll, taxes, and interest of 1.26 M.
About 65.0% of Vycor Medical outstanding shares are owned by insiders

Other Information on Investing in Vycor OTC Stock

Vycor Medical financial ratios help investors to determine whether Vycor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vycor with respect to the benefits of owning Vycor Medical security.